Search Results 851-860 of 17068 for Azithromycin

1. Olmesartan (oral route) - Side effects & dosage - Mayo Clinic

   This can damage the blood vessels of the brain, heart, and kidneys, resulting in a stroke, heart failure, or kidney failure. Lowering blood pressure can reduce ...

2. Study to Analyze the Metabolic Environment in Preventing Atopic Dermatitis - Mayo Clinic

   About this study. The purpose of this study is to compare the assessment of the composition of the fecal, nasal,oral and skin microbiota in patients with AD ...

3. A Study to See if Tolvaptan Can Delay Dialysis in Infants and Children Who at Enrollment Are 28 Days to Less Than 12 Weeks Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD) - Mayo Clinic

   The primary objective of this study is to evaluate the effect of tolvaptan on the need for renal replacement therapy in pediatric subjects with autosomal ...

4. A Study to Evaluate Surgical Sterility, the Microbiome and Infections Following Mastectomy with Immediate / Tissue Expander Reconstruction - Mayo Clinic

   The purpose of this study is to evaluate surgical sterility, the microbiome, and infections post mastectomy with immediate/tissue expander surgery by using OR ...

5. A Study to Assess the Effectiveness and Safety of REGN3500 Monotherapy and Combination of REGN3500 Plus Dupilumab in Adult Patients With Moderate-to-Severe Atopic Dermatitis - Mayo Clinic

   The primary purpose of this study is to evaluate the effectiveness of REGN3500 monotherapy compared with placebo treatment in adult patients with moderate-to- ...

6. Atrasentan (oral route) - Side effects & dosage - Mayo Clinic

   Atrasentan is used to reduce levels of protein in the urine (proteinuria) in patients who have a kidney disease called primary immunoglobulin A nephropathy ( ...

7. Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

8. Evaluating the Safety, Tolerability and Effectiveness of ADX-629 t to Treat Chronic Cough - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

9. Taselisib and Enzalutamide in Treating Patients With Androgen Receptor Positive Triple-Negative Metastatic Breast Cancer - Mayo Clinic

   Taselisib is a PI3K inhibitor. The PI3K pathway is involved is cancer growth. Androgen may cause the growth of tumor cells. Enzalutamide may stop the growth of ...

10. A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower130) - Mayo Clinic

    Clinical Trials · A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With ...